Pecqueux, C., Arslan, A., Heller, M., Falkenstein, M., Kaczorowski, A., Tolstov, Y., . . . Duensing, S. (2018). FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer. Urologic oncology, 36(8), . https://doi.org/10.1016/j.urolonc.2018.05.020
Chicago-Zitierstil (17. Ausg.)Pecqueux, Carine, et al. "FGF-2 Is a Driving Force for Chromosomal Instability and a Stromal Factor Associated with Adverse Clinico-pathological Features in Prostate Cancer." Urologic Oncology 36, no. 8 (2018). https://doi.org/10.1016/j.urolonc.2018.05.020.
MLA-Zitierstil (9. Ausg.)Pecqueux, Carine, et al. "FGF-2 Is a Driving Force for Chromosomal Instability and a Stromal Factor Associated with Adverse Clinico-pathological Features in Prostate Cancer." Urologic Oncology, vol. 36, no. 8, 2018, https://doi.org/10.1016/j.urolonc.2018.05.020.